Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Research on Social Work Practice|March 17, 2017
Applying Structural Systems Thinking to Frame Perspectives on Social Work InnovationErin J Stringfellow
The American Journal on Addictions|August 6, 2024
State-level racial and ethnic disparities in buprenorphine treatment duration in the United StatesHuiru Dong, Erin J Stringfellow, Mohammad S Jalali
Health Affairs (Project Hope)|September 3, 2024
State Mandates On Naloxone Coprescribing Associated With Short-Term Increase In Naloxone CodispensingHuiru Dong, Erin J Stringfellow, Alton Russell, et al.
Journal of General Internal Medicine|January 29, 2026
Prescription Depressant-Involved Overdose Mortality in Massachusetts (2000-2023): A Cohort StudyHannah Lee, Huiru Dong, Mohammad S Jalali, et al.
The International Journal on Drug Policy|January 27, 2025
Stimulant-involved overdose deaths: Constructing dynamic hypothesesZeynep Hasgul, Arielle R Deutsch, Mohammad S Jalali, et al.
The American Journal of Drug and Alcohol Abuse|September 15, 2020
Some law enforcement officers' negative attitudes toward overdose victims are exacerbated following overdose education trainingRachel P Winograd, Erin J Stringfellow, Sarah K Phillips, et al.
PNAS Nexus|April 6, 2023
Enumerating contributions of fentanyls and other factors to the unprecedented 2020 rise in opioid overdose deaths: model-based analysisErin J Stringfellow, Tse Yang Lim, Catherine DiGennaro, et al.
Addiction (Abingdon, England)|July 12, 2023
The association between longitudinal trends in receipt of buprenorphine for opioid use disorder and buprenorphine-waivered providers in the United StatesErin J Stringfellow, Tse Yang Lim, Huiru Dong, et al.
Public Health Reports (Washington, D.C. : 1974)|December 24, 2024
Uncovering Patterns in Overdose Deaths: An Analysis of Spike Identification in Fatal Drug Overdose Data in Massachusetts, 2017-2023Hannah Lee, Daniel Otero-Leon, Huiru Dong, et al.
Addiction (Abingdon, England)|February 25, 2025
The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021Erin J Stringfellow, Huiru Dong, Seyedeh Nazanin Khatami, et al.
Pageof 3